| Code | Description | Claims | Beneficiaries | Total Paid |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
105,443 |
94,774 |
$15.48M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
90,498 |
85,290 |
$10.89M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
72,956 |
65,954 |
$10.80M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
84,277 |
79,962 |
$10.04M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
68,587 |
62,985 |
$9.82M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
58,094 |
52,943 |
$9.43M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
106,194 |
29,465 |
$6.65M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
19,574 |
15,831 |
$6.54M |
| G0378 |
Hospital observation service, per hour |
23,509 |
13,322 |
$3.12M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
108,682 |
84,379 |
$2.96M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,612 |
12,821 |
$2.94M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
16,122 |
15,572 |
$2.16M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12,486 |
11,760 |
$2.15M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
14,228 |
10,995 |
$2.08M |
| 59025 |
Fetal non-stress test |
7,978 |
5,442 |
$2.02M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
17,192 |
16,605 |
$1.75M |
| 70450 |
Computed tomography, head or brain; without contrast material |
12,970 |
11,886 |
$1.74M |
| 76830 |
Ultrasound, transvaginal |
14,338 |
13,876 |
$1.43M |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
18,383 |
17,976 |
$1.38M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
28,090 |
26,122 |
$1.35M |
| 76801 |
|
9,799 |
8,433 |
$1.33M |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
1,072 |
1,054 |
$1.30M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,078 |
1,047 |
$1.18M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
26,179 |
22,290 |
$1.11M |
| 97161 |
|
15,346 |
14,333 |
$1.10M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
7,235 |
6,647 |
$1.09M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,406 |
6,457 |
$1.05M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,422 |
1,352 |
$1.02M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
5,494 |
3,117 |
$994K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
6,407 |
5,841 |
$969K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
7,893 |
7,607 |
$959K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
34,680 |
32,929 |
$929K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
33,616 |
31,928 |
$895K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
7,299 |
6,943 |
$850K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
12,464 |
8,563 |
$810K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,444 |
4,102 |
$805K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
40,954 |
13,167 |
$805K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,571 |
3,321 |
$767K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
5,601 |
4,326 |
$738K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
10,022 |
7,400 |
$718K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,707 |
4,705 |
$706K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
2,503 |
2,345 |
$689K |
| 93971 |
|
3,045 |
2,842 |
$662K |
| 71046 |
Radiologic examination, chest; 2 views |
29,999 |
27,869 |
$657K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
137,266 |
113,859 |
$654K |
| 93975 |
|
4,772 |
4,465 |
$650K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,704 |
1,554 |
$647K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,807 |
3,578 |
$644K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,992 |
1,937 |
$609K |
| 76642 |
|
5,732 |
5,542 |
$607K |
| 81513 |
|
7,350 |
7,007 |
$604K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,112 |
4,101 |
$598K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,586 |
2,527 |
$573K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
16,226 |
5,771 |
$495K |
| 76813 |
|
3,094 |
2,987 |
$491K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
19,361 |
18,939 |
$484K |
| 96367 |
|
2,873 |
1,964 |
$473K |
| 76536 |
|
3,729 |
3,636 |
$457K |
| 73562 |
|
12,205 |
11,476 |
$441K |
| 76770 |
|
2,846 |
2,712 |
$441K |
| 84443 |
Thyroid stimulating hormone (TSH) |
47,982 |
45,028 |
$434K |
| 87428 |
|
7,889 |
7,622 |
$430K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,774 |
2,763 |
$418K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
74,429 |
70,502 |
$412K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
23,274 |
15,991 |
$396K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,109 |
2,056 |
$373K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
10,501 |
9,913 |
$353K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,501 |
3,299 |
$339K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,417 |
2,626 |
$337K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,577 |
2,543 |
$323K |
| 94060 |
|
3,434 |
3,244 |
$316K |
| 80053 |
Comprehensive metabolic panel |
79,396 |
71,222 |
$307K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
96,526 |
77,299 |
$304K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
18,901 |
18,010 |
$298K |
| 12001 |
|
1,774 |
1,724 |
$298K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
21,050 |
13,970 |
$296K |
| 73030 |
|
8,964 |
8,310 |
$293K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
310 |
296 |
$285K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
30,266 |
26,055 |
$280K |
| 73630 |
|
8,886 |
8,197 |
$273K |
| 93017 |
|
2,766 |
2,520 |
$266K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,005 |
1,912 |
$265K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
4,770 |
3,926 |
$262K |
| 80050 |
General health panel |
15,070 |
14,999 |
$255K |
| 73130 |
|
7,536 |
6,827 |
$247K |
| 82805 |
|
7,866 |
6,469 |
$247K |
| 99218 |
|
5,274 |
3,742 |
$245K |
| 73221 |
|
877 |
856 |
$239K |
| 85027 |
|
51,362 |
46,235 |
$238K |
| 71250 |
|
3,349 |
3,191 |
$234K |
| 87390 |
|
13,575 |
13,286 |
$231K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12,811 |
12,267 |
$226K |
| 80061 |
Lipid panel |
60,865 |
58,691 |
$225K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
8,928 |
8,805 |
$222K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
532 |
519 |
$221K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,777 |
1,761 |
$221K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
56,316 |
48,509 |
$216K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
7,457 |
7,116 |
$213K |
| 87481 |
|
7,444 |
7,103 |
$213K |
| 81025 |
|
37,537 |
34,863 |
$212K |
| 84484 |
|
26,325 |
21,112 |
$211K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
25,558 |
19,938 |
$208K |
| 84702 |
|
16,247 |
13,126 |
$208K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
33,257 |
30,259 |
$207K |
| 10060 |
|
1,280 |
1,220 |
$203K |
| 95886 |
|
672 |
588 |
$202K |
| 77066 |
Tomosynthesis, mammo |
2,773 |
2,688 |
$200K |
| 88142 |
|
12,103 |
11,984 |
$196K |
| 73610 |
|
6,677 |
6,193 |
$195K |
| J1756 |
Injection, iron sucrose, 1 mg |
2,470 |
952 |
$194K |
| 99220 |
|
1,379 |
1,279 |
$191K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,122 |
15,493 |
$185K |
| 73110 |
|
5,013 |
4,564 |
$179K |
| 87480 |
|
10,630 |
9,892 |
$172K |
| 87510 |
|
10,627 |
9,890 |
$171K |
| 87660 |
|
10,620 |
9,885 |
$171K |
| 90715 |
|
7,468 |
7,259 |
$169K |
| 83880 |
|
9,961 |
8,393 |
$164K |
| 90686 |
|
10,967 |
10,577 |
$162K |
| 73502 |
|
5,190 |
4,847 |
$154K |
| 86803 |
|
14,639 |
14,208 |
$153K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,599 |
2,597 |
$148K |
| 72100 |
|
4,463 |
4,289 |
$144K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,022 |
991 |
$143K |
| 77080 |
|
2,295 |
2,243 |
$143K |
| 97165 |
|
1,954 |
1,708 |
$142K |
| 86780 |
|
12,649 |
12,316 |
$136K |
| 94727 |
|
3,102 |
2,936 |
$136K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,923 |
14,805 |
$135K |
| 71271 |
|
2,480 |
2,430 |
$130K |
| 82728 |
|
14,871 |
13,703 |
$128K |
| 72110 |
|
3,325 |
3,173 |
$126K |
| 83690 |
|
24,424 |
21,591 |
$120K |
| ATP08 |
|
18,291 |
16,036 |
$119K |
| 83735 |
|
29,512 |
20,178 |
$119K |
| 76820 |
|
3,215 |
2,360 |
$116K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,501 |
1,483 |
$115K |
| 81001 |
|
49,046 |
44,448 |
$113K |
| 82607 |
|
12,841 |
12,019 |
$113K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
4,715 |
4,359 |
$112K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
5,026 |
4,264 |
$108K |
| 74183 |
|
275 |
274 |
$107K |
| 62323 |
|
172 |
170 |
$107K |
| ATP15 |
|
12,344 |
10,463 |
$106K |
| 93270 |
|
9,502 |
4,317 |
$105K |
| 12011 |
|
634 |
626 |
$104K |
| 72141 |
|
446 |
428 |
$102K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,593 |
2,588 |
$97K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
290 |
287 |
$95K |
| 86618 |
|
7,112 |
3,919 |
$93K |
| 97802 |
|
1,020 |
1,017 |
$91K |
| 80076 |
|
37,664 |
32,956 |
$90K |
| 77065 |
Tomosynthesis, mammo |
1,087 |
1,069 |
$85K |
| 94618 |
|
846 |
786 |
$83K |
| 74018 |
|
2,169 |
2,015 |
$82K |
| 87340 |
|
9,846 |
9,548 |
$81K |
| 83970 |
|
3,678 |
3,493 |
$79K |
| 97803 |
|
900 |
853 |
$75K |
| 94729 |
|
3,177 |
3,005 |
$75K |
| 85379 |
|
10,810 |
9,970 |
$72K |
| 73140 |
|
2,140 |
2,006 |
$69K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
775 |
734 |
$67K |
| 85610 |
|
27,703 |
19,746 |
$67K |
| 93970 |
|
333 |
309 |
$66K |
| 82746 |
|
7,818 |
7,240 |
$66K |
| 73080 |
|
2,096 |
1,984 |
$65K |
| 88342 |
|
2,222 |
2,059 |
$65K |
| 86850 |
|
10,287 |
9,457 |
$64K |
| 87186 |
|
10,683 |
9,881 |
$64K |
| 87081 |
|
11,414 |
10,987 |
$64K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
598 |
580 |
$64K |
| 29125 |
|
683 |
667 |
$64K |
| 87653 |
|
2,121 |
2,092 |
$63K |
| 83605 |
|
8,692 |
6,940 |
$63K |
| 82570 |
|
19,695 |
18,545 |
$61K |
| 83540 |
|
14,874 |
13,688 |
$61K |
| ATP14 |
|
10,869 |
9,849 |
$59K |
| 84439 |
|
10,466 |
9,871 |
$58K |
| 12002 |
|
379 |
365 |
$58K |
| 87631 |
|
521 |
507 |
$57K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,435 |
1,613 |
$55K |
| 83550 |
|
10,051 |
9,170 |
$55K |
| 81003 |
|
33,231 |
31,226 |
$54K |
| 86762 |
|
4,363 |
4,227 |
$54K |
| 82043 |
|
17,491 |
16,690 |
$54K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,165 |
6,133 |
$53K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
957 |
909 |
$53K |
| 76882 |
|
484 |
459 |
$52K |
| 96415 |
|
343 |
222 |
$51K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
153 |
144 |
$51K |
| 83721 |
|
9,897 |
9,385 |
$50K |
| 80074 |
|
1,310 |
1,280 |
$49K |
| 86787 |
|
4,151 |
4,043 |
$49K |
| 84146 |
|
3,298 |
3,163 |
$48K |
| 99215 |
Prolong outpt/office vis |
213 |
209 |
$48K |
| 72050 |
|
1,033 |
1,012 |
$47K |
| 86003 |
|
1,026 |
543 |
$47K |
| 82784 |
|
6,738 |
3,631 |
$46K |
| 99217 |
|
835 |
795 |
$46K |
| 73564 |
|
732 |
710 |
$46K |
| 77002 |
|
247 |
235 |
$44K |
| 71045 |
Radiologic examination, chest; single view |
10,693 |
9,527 |
$44K |
| 87420 |
|
4,007 |
3,868 |
$43K |
| 87040 |
|
4,423 |
3,664 |
$43K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
4,591 |
4,445 |
$42K |
| 70491 |
|
313 |
292 |
$40K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
405 |
200 |
$39K |
| 97162 |
|
533 |
506 |
$39K |
| 86334 |
|
3,160 |
2,888 |
$38K |
| 86140 |
|
10,669 |
9,558 |
$37K |
| 87522 |
Neg quan hep c or qual rna |
1,043 |
1,016 |
$37K |
| 90677 |
|
858 |
833 |
$37K |
| 72040 |
|
700 |
689 |
$37K |
| S9485 |
Crisis intervention mental health services, per diem |
94 |
52 |
$37K |
| 86706 |
|
4,545 |
4,363 |
$36K |
| 86704 |
|
4,012 |
3,846 |
$35K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
436 |
415 |
$35K |
| 84100 |
|
21,185 |
13,850 |
$34K |
| 70486 |
|
779 |
742 |
$34K |
| 83001 |
|
2,154 |
2,115 |
$33K |
| 84145 |
|
5,104 |
3,947 |
$33K |
| 88304 |
|
2,366 |
2,243 |
$33K |
| 86696 |
|
1,297 |
1,256 |
$33K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
664 |
334 |
$32K |
| 84403 |
|
1,665 |
1,595 |
$31K |
| 90750 |
|
555 |
550 |
$31K |
| 93296 |
|
1,086 |
1,011 |
$31K |
| 86900 |
|
12,052 |
10,993 |
$31K |
| 83021 |
|
1,949 |
1,905 |
$31K |
| 76886 |
|
209 |
204 |
$31K |
| 87088 |
|
5,445 |
5,114 |
$31K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
315 |
314 |
$30K |
| 84703 |
|
4,906 |
4,620 |
$29K |
| 92551 |
|
289 |
287 |
$29K |
| Q3014 |
Telehealth originating site facility fee |
12,457 |
11,255 |
$29K |
| 82962 |
|
13,915 |
8,634 |
$28K |
| 86901 |
|
11,991 |
10,932 |
$28K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,881 |
1,790 |
$28K |
| 82670 |
|
1,103 |
1,086 |
$28K |
| 84425 |
|
1,714 |
1,662 |
$27K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
3,798 |
1,769 |
$27K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
704 |
657 |
$27K |
| 85652 |
|
14,417 |
13,076 |
$26K |
| 96376 |
|
8,276 |
4,956 |
$26K |
| 87070 |
|
4,233 |
3,872 |
$25K |
| 86235 |
|
674 |
346 |
$25K |
| 85730 |
|
6,357 |
5,604 |
$25K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
713 |
707 |
$25K |
| 84165 |
|
3,339 |
3,051 |
$24K |
| 86038 |
|
2,769 |
2,604 |
$24K |
| 83516 |
|
1,813 |
1,244 |
$23K |
| 86708 |
|
2,426 |
2,359 |
$23K |
| 86480 |
|
516 |
493 |
$23K |
| ATP17 |
|
8,491 |
7,669 |
$22K |
| 73590 |
|
1,256 |
1,162 |
$22K |
| 97035 |
|
322 |
138 |
$22K |
| 86695 |
|
1,299 |
1,256 |
$22K |
| ATP09 |
|
3,382 |
2,543 |
$22K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
11,627 |
8,863 |
$22K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
23,316 |
18,708 |
$22K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
16,932 |
10,808 |
$22K |
| 87147 |
|
5,040 |
4,745 |
$22K |
| 87077 |
|
4,671 |
4,324 |
$21K |
| 84402 |
|
921 |
903 |
$20K |
| J2704 |
Injection, propofol, 10 mg |
17,874 |
13,497 |
$20K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
7,032 |
5,946 |
$20K |
| 84480 |
|
2,107 |
1,995 |
$19K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
22,368 |
15,926 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
48,431 |
39,405 |
$19K |
| 72197 |
|
48 |
48 |
$18K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
841 |
696 |
$18K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,936 |
1,888 |
$18K |
| 99173 |
|
431 |
430 |
$18K |
| G0008 |
Administration of influenza virus vaccine |
4,259 |
4,053 |
$17K |
| 80179 |
|
2,926 |
2,629 |
$17K |
| ATP16 |
|
1,935 |
1,495 |
$17K |
| 0240U |
|
412 |
395 |
$17K |
| 90670 |
|
1,782 |
1,765 |
$16K |
| 99381 |
|
103 |
102 |
$16K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
17 |
14 |
$16K |
| 76870 |
|
166 |
160 |
$16K |
| 72072 |
|
442 |
434 |
$16K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,989 |
4,333 |
$15K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20,666 |
15,913 |
$15K |
| 83002 |
|
862 |
860 |
$15K |
| 82950 |
|
3,274 |
3,247 |
$14K |
| 90662 |
|
1,461 |
1,338 |
$14K |
| 93299 |
|
466 |
432 |
$14K |
| 80143 |
|
2,789 |
2,485 |
$14K |
| 82565 |
|
9,521 |
8,850 |
$13K |
| 80171 |
|
1,489 |
1,445 |
$13K |
| 87205 |
|
4,204 |
3,807 |
$13K |
| 84466 |
|
1,182 |
1,161 |
$13K |
| 87338 |
|
1,144 |
1,131 |
$13K |
| 70496 |
|
115 |
104 |
$13K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
5,535 |
4,486 |
$12K |
| 19083 |
|
12 |
12 |
$12K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
935 |
777 |
$11K |
| 73090 |
|
607 |
566 |
$11K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,912 |
2,047 |
$11K |
| 85045 |
|
4,234 |
3,887 |
$11K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
7,366 |
6,010 |
$10K |
| 88300 |
|
288 |
268 |
$10K |
| 84460 |
|
7,713 |
7,113 |
$10K |
| 84550 |
|
5,253 |
4,681 |
$10K |
| 20610 |
|
45 |
42 |
$9K |
| 83883 |
|
1,236 |
791 |
$9K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
327 |
324 |
$9K |
| 84153 |
|
1,130 |
1,050 |
$9K |
| 82550 |
|
5,296 |
4,680 |
$9K |
| 82747 |
|
609 |
604 |
$9K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
171 |
165 |
$9K |
| 90746 |
|
314 |
313 |
$9K |
| 71101 |
|
385 |
368 |
$9K |
| 86709 |
|
911 |
905 |
$9K |
| 90651 |
|
866 |
863 |
$9K |
| 90732 |
|
361 |
361 |
$9K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
3,638 |
3,375 |
$9K |
| 90656 |
|
787 |
783 |
$9K |
| 83010 |
|
1,027 |
956 |
$9K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
9,836 |
7,055 |
$8K |
| 84450 |
|
7,033 |
6,463 |
$8K |
| ATP02 |
|
2,496 |
2,116 |
$8K |
| 86765 |
|
626 |
620 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
282 |
275 |
$8K |
| 84520 |
|
7,205 |
6,687 |
$8K |
| 92552 |
|
50 |
50 |
$8K |
| 87899 |
|
734 |
406 |
$8K |
| 86735 |
|
598 |
592 |
$8K |
| 76942 |
|
27 |
26 |
$7K |
| 90620 |
|
446 |
442 |
$7K |
| 97014 |
|
78 |
27 |
$7K |
| 83615 |
|
3,790 |
3,374 |
$7K |
| 86160 |
|
532 |
367 |
$7K |
| 86666 |
|
507 |
264 |
$7K |
| 84156 |
|
2,368 |
1,948 |
$7K |
| 88313 |
|
393 |
368 |
$7K |
| 84132 |
|
4,616 |
4,251 |
$7K |
| 87046 |
|
841 |
458 |
$6K |
| 86317 |
|
372 |
363 |
$6K |
| 74019 |
|
558 |
507 |
$6K |
| 95909 |
|
35 |
35 |
$6K |
| 80164 |
|
1,438 |
1,299 |
$6K |
| 84255 |
|
245 |
244 |
$6K |
| 84155 |
|
2,990 |
2,730 |
$6K |
| 85018 |
|
2,845 |
2,586 |
$5K |
| 82247 |
|
2,788 |
1,962 |
$5K |
| 82150 |
|
998 |
959 |
$5K |
| 86617 |
|
351 |
187 |
$5K |
| 82465 |
|
1,136 |
1,105 |
$5K |
| J2785 |
Injection, regadenoson, 0.1 mg |
268 |
242 |
$5K |
| ATP03 |
|
4,868 |
4,488 |
$5K |
| 86430 |
|
1,018 |
986 |
$5K |
| 90694 |
|
514 |
511 |
$5K |
| 84144 |
|
241 |
207 |
$4K |
| 82525 |
|
421 |
412 |
$4K |
| 86376 |
|
343 |
337 |
$4K |
| 86039 |
|
500 |
472 |
$4K |
| ATP05 |
|
856 |
766 |
$4K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,252 |
1,113 |
$4K |
| 87045 |
|
470 |
444 |
$4K |
| 82172 |
|
267 |
259 |
$4K |
| 84630 |
|
395 |
391 |
$4K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
23 |
13 |
$4K |
| 85014 |
|
2,227 |
1,984 |
$4K |
| 82947 |
|
1,960 |
1,851 |
$4K |
| 88312 |
|
54 |
54 |
$4K |
| 82785 |
|
271 |
263 |
$4K |
| 20552 |
|
13 |
13 |
$4K |
| 90716 |
|
446 |
443 |
$4K |
| 84295 |
|
1,722 |
1,624 |
$4K |
| 82627 |
|
172 |
172 |
$4K |
| 87015 |
|
745 |
686 |
$4K |
| 93225 |
|
40 |
39 |
$4K |
| 82274 |
|
228 |
226 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,284 |
1,287 |
$3K |
| 93226 |
|
38 |
37 |
$3K |
| 90707 |
|
494 |
492 |
$3K |
| J2060 |
Injection, lorazepam, 2 mg |
5,685 |
3,915 |
$3K |
| 86255 |
|
107 |
54 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
7,340 |
4,402 |
$3K |
| 86753 |
|
286 |
148 |
$3K |
| 86200 |
|
215 |
213 |
$3K |
| 73560 |
|
55 |
54 |
$3K |
| ATP07 |
|
741 |
675 |
$3K |
| 86580 |
|
249 |
237 |
$2K |
| 97760 |
|
48 |
37 |
$2K |
| 90653 |
|
300 |
300 |
$2K |
| 82140 |
|
452 |
369 |
$2K |
| 82310 |
|
968 |
952 |
$2K |
| 87625 |
|
68 |
68 |
$2K |
| 0071A |
|
51 |
51 |
$2K |
| 82040 |
|
1,003 |
962 |
$2K |
| 73552 |
|
65 |
62 |
$2K |
| 99224 |
|
74 |
39 |
$2K |
| 97018 |
|
29 |
26 |
$2K |
| 94760 |
|
5,227 |
4,699 |
$2K |
| 82652 |
|
63 |
62 |
$2K |
| 88311 |
|
70 |
67 |
$2K |
| 87329 |
|
200 |
190 |
$2K |
| 85007 |
|
985 |
794 |
$2K |
| 90688 |
|
51 |
51 |
$2K |
| 0072A |
|
40 |
40 |
$2K |
| 93298 |
|
84 |
76 |
$2K |
| 87328 |
|
186 |
177 |
$2K |
| 72131 |
|
41 |
39 |
$2K |
| 82977 |
|
647 |
628 |
$2K |
| 82668 |
|
147 |
136 |
$2K |
| 99188 |
|
46 |
46 |
$2K |
| 82378 |
|
115 |
90 |
$2K |
| 84481 |
|
102 |
102 |
$1K |
| 72081 |
|
27 |
27 |
$1K |
| J3411 |
Injection, thiamine hcl, 100 mg |
25 |
12 |
$1K |
| 87181 |
|
581 |
542 |
$1K |
| 83520 |
|
127 |
122 |
$1K |
| 86308 |
|
307 |
294 |
$1K |
| 82533 |
|
98 |
94 |
$1K |
| 86225 |
|
128 |
122 |
$1K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
14 |
14 |
$1K |
| 82077 |
|
271 |
241 |
$1K |
| 95913 |
|
12 |
12 |
$1K |
| 87493 |
|
55 |
51 |
$1K |
| 83986 |
|
641 |
613 |
$1K |
| ATP18 |
|
670 |
560 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
278 |
250 |
$1K |
| 99234 |
|
12 |
12 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,142 |
1,670 |
$1K |
| G0009 |
Administration of pneumococcal vaccine |
513 |
494 |
$984.24 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
6,143 |
5,335 |
$977.22 |
| ATP10 |
|
435 |
382 |
$974.06 |
| Q9960 |
High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml |
1,297 |
1,139 |
$950.16 |
| 92083 |
|
28 |
28 |
$939.49 |
| 69209 |
|
71 |
71 |
$939.26 |
| 82951 |
|
77 |
74 |
$926.93 |
| 73060 |
|
44 |
40 |
$923.09 |
| 83525 |
|
81 |
81 |
$912.65 |
| 92133 |
|
25 |
25 |
$871.91 |
| ATP11 |
|
412 |
351 |
$763.28 |
| 86880 |
|
216 |
206 |
$721.89 |
| 74220 |
|
12 |
12 |
$695.18 |
| 0001A |
|
15 |
15 |
$688.20 |
| 83498 |
|
24 |
24 |
$672.24 |
| 82248 |
|
1,515 |
1,119 |
$656.27 |
| 93246 |
|
238 |
223 |
$650.05 |
| 80051 |
|
209 |
202 |
$617.24 |
| ATP13 |
|
250 |
237 |
$598.95 |
| 84311 |
|
413 |
397 |
$538.80 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
266 |
182 |
$502.41 |
| 73523 |
|
12 |
12 |
$502.41 |
| 86431 |
|
92 |
91 |
$494.14 |
| 80178 |
|
196 |
173 |
$483.16 |
| 86769 |
|
12 |
12 |
$469.90 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
924 |
577 |
$466.53 |
| 74174 |
|
12 |
12 |
$462.72 |
| 82340 |
|
106 |
103 |
$453.68 |
| 93242 |
|
206 |
203 |
$447.19 |
| 90734 |
|
134 |
133 |
$423.61 |
| 70498 |
|
91 |
79 |
$417.36 |
| 90461 |
|
219 |
213 |
$410.95 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
685 |
671 |
$392.85 |
| 87184 |
|
123 |
110 |
$384.47 |
| 86800 |
|
27 |
27 |
$381.36 |
| ATP04 |
|
113 |
104 |
$362.90 |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
616 |
597 |
$350.61 |
| 87255 |
|
12 |
12 |
$347.79 |
| 80069 |
|
110 |
102 |
$325.47 |
| 82330 |
|
31 |
29 |
$319.02 |
| ATP23 |
|
32 |
26 |
$314.73 |
| 70360 |
|
12 |
12 |
$302.52 |
| 90696 |
|
245 |
245 |
$298.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,137 |
817 |
$286.23 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
535 |
478 |
$278.23 |
| 88173 |
|
13 |
13 |
$261.56 |
| 87425 |
|
22 |
22 |
$240.68 |
| 90633 |
|
879 |
876 |
$210.71 |
| 90632 |
|
13 |
12 |
$203.60 |
| 76376 |
|
1,639 |
1,599 |
$202.32 |
| 87324 |
|
33 |
27 |
$192.42 |
| 80177 |
|
46 |
43 |
$191.38 |
| 83718 |
|
28 |
27 |
$187.96 |
| S9083 |
Global fee urgent care centers |
292 |
285 |
$179.72 |
| 81050 |
|
65 |
65 |
$175.98 |
| 96417 |
|
34 |
26 |
$172.54 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,164 |
484 |
$169.27 |
| ATP06 |
|
69 |
60 |
$105.04 |
| 82948 |
|
23 |
21 |
$102.70 |
| 88112 |
|
18 |
12 |
$79.38 |
| 80156 |
|
13 |
12 |
$75.15 |
| 85049 |
|
12 |
12 |
$51.79 |
| 82952 |
|
14 |
14 |
$50.12 |
| J0713 |
Injection, ceftazidime, per 500 mg |
173 |
114 |
$48.15 |
| 84075 |
|
13 |
12 |
$43.90 |
| 15853 |
|
14 |
14 |
$39.24 |
| 82272 |
|
14 |
12 |
$38.56 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
153 |
134 |
$27.02 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
77 |
29 |
$27.00 |
| 82270 |
|
13 |
12 |
$26.88 |
| 90710 |
|
76 |
76 |
$19.06 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
68 |
64 |
$18.13 |
| 90713 |
|
14 |
14 |
$14.16 |
| J1815 |
Injection, insulin, per 5 units |
59 |
25 |
$8.33 |
| C9113 |
Injection, pantoprazole sodium, per vial |
2,185 |
1,446 |
$8.15 |
| 96368 |
|
33 |
25 |
$0.00 |
| C1769 |
Guide wire |
225 |
183 |
$0.00 |
| 90680 |
|
41 |
40 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
204 |
195 |
$0.00 |
| 90697 |
|
336 |
336 |
$0.00 |
| 90723 |
|
650 |
649 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
45 |
42 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
93 |
79 |
$0.00 |
| 80320 |
|
115 |
109 |
$0.00 |
| 94761 |
|
393 |
360 |
$0.00 |
| J0515 |
Injection, benztropine mesylate, per 1 mg |
113 |
68 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
23 |
22 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
12 |
12 |
$0.00 |
| 90744 |
|
16 |
16 |
$0.00 |
| 84478 |
|
21 |
13 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
85 |
78 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
159 |
96 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
82 |
63 |
$0.00 |
| 80329 |
|
65 |
61 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
15 |
12 |
$0.00 |
| 91307 |
|
21 |
16 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
15 |
14 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
16 |
16 |
$0.00 |
| 90648 |
|
1,041 |
1,037 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
511 |
467 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
3,616 |
2,916 |
$0.00 |
| 99053 |
|
15 |
14 |
$0.00 |
| 99221 |
|
28 |
27 |
$0.00 |
| 90700 |
|
335 |
332 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
76 |
75 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
662 |
590 |
$0.00 |
| 90681 |
|
310 |
310 |
$0.00 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
70 |
44 |
$0.00 |
| 90649 |
|
13 |
12 |
$0.00 |
| 90685 |
|
32 |
32 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
199 |
107 |
$0.00 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
21 |
13 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
29 |
29 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
20 |
13 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
14 |
12 |
$0.00 |
| 87563 |
|
18 |
15 |
$0.00 |